Outcomes of SARS-CoV-2 Infection in Patients with Chronic Liver Disease and Cirrhosis: a N3C Study

BACKGROUND AND AIMS: In patients with chronic liver diseases (CLD) with or without cirrhosis, existing data on the risk of adverse outcomes with SARS-CoV-2 infection have been mixed or have limited generalizability. We used the National COVID Cohort Collaborative (N3C) Data Enclave, a harmonized ele...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Jin, Pletcher, Mark J., Lai, Jennifer C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202438/
https://www.ncbi.nlm.nih.gov/pubmed/34127981
http://dx.doi.org/10.1101/2021.06.03.21258312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202438/
https://www.ncbi.nlm.nih.gov/pubmed/34127981
http://dx.doi.org/10.1101/2021.06.03.21258312

Ejemplares similares